Jakob R. Passweg
Expertise in
23
conditions

Jakob R. Passweg

Basel, BS, CH 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
23
conditions
Basel, BS, CH 

Overview

Jakob Passweg practices practicing medicine in Basel, Switzerland.

Mr. Passweg is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Aplastic Anemia, Graft Versus Host Disease (GvHD), Leukemia, Bone Marrow Transplant, and Bone Graft.

He is actively involved in clinical research, co-authoring 464 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Basel, BS 4031, Switzerland
Other Locations
Zurich, ZH, Switzerland
Bern, BE, Switzerland
Geneve, GE, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase I/II Single Center Study to Assess the Safety, Tolerability and Feasibility of Pre-emptive Immunotherapy With in Vitro Expanded Natural Killer Cells in Patients Treated With Haplo-HSCT for AML/MDS
A Phase I/II Single Center Study to Assess the Safety, Tolerability and Feasibility of Pre-emptive Immunotherapy With in Vitro Expanded Natural Killer Cells in Patients Treated With Haplo-HSCT for AML/MDS
Enrollment Status: Recruiting
Publish Date: December 04, 2025
Intervention Type: Other
Study Phase: Phase 1/Phase 2
The Skin Microbiome in Graft Versus Host Disease Dynamics of the Skin-microbiota After Allogeneic Stem Cell Transplantation - a Predictive Marker for Graft Versus Host Disease?
The Skin Microbiome in Graft Versus Host Disease Dynamics of the Skin-microbiota After Allogeneic Stem Cell Transplantation - a Predictive Marker for Graft Versus Host Disease?
Enrollment Status: Active_not_recruiting
Publish Date: April 03, 2025
Intervention Type: Diagnostic test
A Phase I/II Single Center Study to Assess Tolerability and Feasibility of Infusions of Allogeneic Expanded Haploidentical Natural Killer (NK) Cells in Patients Treated With High Dose Melphalan Chemotherapy and Autologous Stem Cell Transplantation for a Multiple Myeloma
A Phase I/II Single Center Study to Assess Tolerability and Feasibility of Infusions of Allogeneic Expanded Haploidentical Natural Killer (NK) Cells in Patients Treated With High Dose Melphalan Chemotherapy and Autologous Stem Cell Transplantation for a Multiple Myeloma
Enrollment Status: Completed
Publish Date: April 04, 2023
Intervention Type: Other
Study Phase: Phase 1/Phase 2
Cyclophosphamide-Busulfan Versus Busulfan-Cyclophosphamide as Conditioning Regimen Before Allogeneic Hematopoietic Stem Cell Transplantation for Leukemia: a Prospective Randomized Study to Assess Liver Toxicity
Cyclophosphamide-Busulfan Versus Busulfan-Cyclophosphamide as Conditioning Regimen Before Allogeneic Hematopoietic Stem Cell Transplantation for Leukemia: a Prospective Randomized Study to Assess Liver Toxicity
Enrollment Status: Completed
Publish Date: March 02, 2018
Intervention Type: Drug
Study Phase: Not Applicable
View 3 Less Clinical Trials

464 Total Publications

Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-A Prospective Study on Behalf of the EBMT Transplant Complications Working Party.
Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-A Prospective Study on Behalf of the EBMT Transplant Complications Working Party.
Journal: Cancers
Published: December 02, 2025

Frequently Asked Questions about Jakob R. Passweg

Is Jakob R. Passweg a top-rated expert for Bone Marrow Transplant?

MediFind is an objective health platform that identifies experts based on real-world data. Jakob R. Passweg is classified as an Elite expert for Bone Marrow Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jakob R. Passweg participate in research or clinical trials?

Yes. Jakob R. Passweg has published 464 articles and abstracts on conditions like Bone Marrow Transplant. You can view a list of Jakob R. Passweg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Passweg's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 47 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile